Bank Mandiri Persero Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bank Mandiri Persero Tbk trades at Rp4,200 (market cap 384.38T, 145.28M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume). The key difference: Bank Mandiri Persero Tbk is far larger — about 1236.9× Diagnos Laboratorium Utama Tbk.'s market cap, and Bank Mandiri Persero Tbk is more actively traded (145.28M versus 963.6K). Which is the better fit depends on your goals.
| BMRI | DGNS | |
|---|---|---|
Market Cap | 384.38T | 310.75B |
Volume | 145.28M | 963.6K |
Lot | 1.45M | 9.64K |
Turnover | 613.36B | 217.67M |
Average Price | 4,221.85 | 225.89 |
Value | 613.36B | 217.67M |
Indicative Equilibrium Price | 4,200 | 226 |
Indicative Equilibrium Volume | 138.7K | 1K |
Trailing returns across standard periods
Latest headlines on both assets
Bank Mandiri was established at 2 Oct 1998 and start in commercial activity at 1 Aug 1999. As a result of merge 4 banks (Bank Bumi Daya, Bank Dagang Negara, Bank Exim and Bapindo), Bank Mandiri is Indonesia's largest national bank (assets) as per Dec 31, 2002. Bank Mandiri main activities are corporate banking, commercial banking and consumer banking.
Read more on BMRI →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →